[PE31] Poster Session 31
Rhinosinusitis

[PE31-17] Impact of eosinophilic status on efficacy of dupilumab in the JESREC subpopulations of phase 3 SINUS-52 study for severe chronic rhinosinusitis with nasal polyps

Shigeharu Fujieda¹, Shoji Matsune², Sachio Takeno³, Nobuo Ohta⁴, Mikiya Asako⁵, Claus Bachert^6,7, Martin Desrosiers⁸, Tomoyuki Inoue⁹, Yoshinori Takahashi⁹, Hiroyuki Fujita⁹, Benjamin Ortiz¹⁰, Yongtao Li¹¹, Nikhil Amin¹⁰, Leda P Mannent¹² (1.Department of Otorhinolaryngology University of Fukui, Japan, 2.Nippon Medical School, Japan, 3.Hiroshima University Hospital, Japan, 4.Tohoku Medical and Pharmaceutical University, Japan, 5.Kansai Medical University, Japan, 6.Ghent University, Belgium, 7.Karolinska Institutet, Sweden, 8.CRCHUM, Canada, 9.Sanofi K.K., Japan, 10.Regeneron Pharmaceuticals, Inc., USA, 11.Sanofi U.S., USA, 12.Sanofi France, France)